Specifically, the overexpression of JARID1B in lung cancer cell line A549 resulted in 3-fold decrease of miR-200a and miR-200c expression while JARID1B knockdown led to 1.5-fold increase of their steady-state levels. Here, KDM5B is linked to lung carcinoma.